CN105395441A - 一种全效控油、祛痘、净痘美肌精华液 - Google Patents
一种全效控油、祛痘、净痘美肌精华液 Download PDFInfo
- Publication number
- CN105395441A CN105395441A CN201511030166.9A CN201511030166A CN105395441A CN 105395441 A CN105395441 A CN 105395441A CN 201511030166 A CN201511030166 A CN 201511030166A CN 105395441 A CN105395441 A CN 105395441A
- Authority
- CN
- China
- Prior art keywords
- extract
- acne
- essence
- skin
- control oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title abstract description 6
- 206010000496 acne Diseases 0.000 title abstract description 6
- 239000000284 extract Substances 0.000 claims abstract description 76
- 230000000694 effects Effects 0.000 claims abstract description 30
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 29
- 244000068988 Glycine max Species 0.000 claims abstract description 17
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000008367 deionised water Substances 0.000 claims abstract description 9
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 9
- 230000003255 anti-acne Effects 0.000 claims description 19
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical class OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 16
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 15
- 244000292839 Ficus religiosa Species 0.000 claims description 11
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 claims description 9
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 claims description 9
- 235000012677 beetroot red Nutrition 0.000 claims description 9
- 239000001654 beetroot red Substances 0.000 claims description 9
- 235000002185 betanin Nutrition 0.000 claims description 9
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 9
- DTTVNCZEOYSFFF-UHFFFAOYSA-N ethoxyurea Chemical compound CCONC(N)=O DTTVNCZEOYSFFF-UHFFFAOYSA-N 0.000 claims description 9
- 230000002421 anti-septic effect Effects 0.000 claims description 2
- -1 antiseptic Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 230000003750 conditioning effect Effects 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 claims description 2
- 239000011148 porous material Substances 0.000 abstract description 11
- 238000009499 grossing Methods 0.000 abstract description 3
- 235000013717 Houttuynia Nutrition 0.000 abstract 2
- 240000000691 Houttuynia cordata Species 0.000 abstract 2
- 241000972672 Phellodendron Species 0.000 abstract 2
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 2
- 239000009136 dragon's blood Substances 0.000 abstract 2
- 150000003872 salicylic acid derivatives Chemical class 0.000 abstract 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 abstract 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 abstract 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 abstract 1
- 229960003237 betaine Drugs 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- 241000700647 Variola virus Species 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000004378 sebocyte Anatomy 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- 102100034278 Annexin A6 Human genes 0.000 description 1
- 108090000656 Annexin A6 Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000089795 Clausena lansium Species 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101710145505 Fiber protein Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000012334 Integrin beta4 Human genes 0.000 description 1
- 108010022238 Integrin beta4 Proteins 0.000 description 1
- 235000010240 Paullinia pinnata Nutrition 0.000 description 1
- 241001119522 Paullinia pinnata Species 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- 241001278097 Salix alba Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 240000003864 Ulex europaeus Species 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000009286 sanguis draxonis Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- MTAWKURMWOXCEO-UHFFFAOYSA-N taspine Chemical compound O1C(=O)C2=C(CCN(C)C)C=C(OC)C3=C2C2=C1C(OC)=CC=C2C(=O)O3 MTAWKURMWOXCEO-UHFFFAOYSA-N 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种全效控油、祛痘、净痘美肌精华液,其包括按重量百分比计的以下组分:野大豆籽提取物0.1-2%、鱼腥草提取物0.5-3%、黄柏提取物1-5%、龙血提取物0.1-1%、水杨酸衍生物5-20ppm、甘油1-5%、丁二醇0.5-10%、羟乙基脲1-3%、甜菜碱0.5-2%、辅助成分0.5-3%及余量去离子水,本发明采用野大豆籽提取物、鱼腥草提取物与龙血提取物、黄柏提取物、水杨酸衍生物的完美搭配,获得具有能帮助肌肤持续控油、畅通毛孔、细致毛孔、祛除痘痘、抚平痘痕、光滑肤感等全方位功效的全效控油、祛痘、净痘美肌精华液。
Description
技术领域
本发明涉及日化用品技术领域,尤其是涉及一种全效控油、祛痘、净痘美肌精华液。
背景技术
随着经济的发展,工作、生活节奏越来越快,精神压力越来越大,加上不良的生活习惯、恶劣环境、紫外线、不正确的皮肤护理等众多因素对皮肤的伤害,越来越多的人都被干燥、粗糙、肤色黯哑、满脸痘痘、粗糙、毛孔粗大等皮肤状况紊乱的综合问题困扰,虽然市场上的护肤品虽然非常丰富,但面对这种综合性问题总不能够很好的解决,常常解决一方面的问题同时又加深了另外的问题。
发明内容
本发明的目的是为了解决上述皮肤护理的困惑,提供了一种具有能帮助肌肤持续控油、畅通毛孔、细致毛孔、祛除痘痘、抚平痘痕、光滑肤感等全方位功效的精华液。
本发明的技术方案为:一种全效控油、祛痘、净痘美肌精华液,其包括按重量百分比计的以下组分:
野大豆籽提取物:0.1-2%
鱼腥草提取物:0.5-3%
黄柏提取物:1-5%
龙血提取物:0.1-1%
水杨酸衍生物:5-20ppm
甘油:1-5%
丁二醇:0.5-10%
羟乙基脲:1-3%
甜菜碱:0.5-2%
辅助成分:0.5-3%
去离子水:余量。
作为本发明的进一步改进,本发明的全效控油、祛痘、净痘美肌精华液,其包括按重量百分比计的以下组分:
野大豆籽提取物:1-2%
鱼腥草提取物:1-3%
黄柏提取物:2-4%
龙血提取物:0.5-1%
水杨酸衍生物:5-20ppm
甘油:1-5%
丁二醇:0.5-10%
羟乙基脲:1-3%
甜菜碱:0.5-2%
辅助成分:0.5-3%
去离子水:余量
作为本发明的进一步改进,本发明的全效控油、祛痘、净痘美肌精华液,其包括按重量百分比计的以下组分:
野大豆籽提取物:1.5%
鱼腥草提取物:2%
黄柏提取物:3%
龙血提取物:1%
水杨酸衍生物:5ppm
甘油:1-5%
丁二醇:0.5-10%
羟乙基脲:1-3%
甜菜碱:0.5-2%
辅助成分:0.5-3%
去离子水:余量,
以上各组分之和为100%
作为本发明的进一步改进,本发明的全效控油、祛痘、净痘美肌精华液,还包括有菩提树(FICUSRELIGIOSA)提取物适量。
所述菩提树(FICUSRELIGIOSA)提取物与龙血提取物的重量比为(0.5~1):1。
所述辅助成分包括并不限于赋香剂、防腐剂、增溶剂、增稠剂、辅助皮肤调理剂。
本发明中的野大豆籽提取物,标准中文名称:野大豆籽提取物(暂无CAS号),从野大豆中提取的活性物,含有丰富微量元素和多种氨基酸,抑制皮脂腺细胞分化和成熟皮脂腺细胞的皮脂分泌量,达到控油、细致毛孔,消除油光外观和肤感的功效.
本发明中的鱼腥草提取物,以干燥鱼腥草为原料,经过溶剂提取而制成的活性物,标准中文名称:鱼腥草提取物(暂无CAS号),能增强机体免疫功能,增加白细胞吞噬能力,具有清热解毒,消肿排脓、镇痛、恢复皮肤屏障功能、保持皮肤的水润、促进皮肤组织再生等功效。
本发明中的黄柏提取物,标准中文名称:黄檗树皮提取物(暂无CAS号),芸香科植物黄皮权或黄檗的干燥树皮提取的活性物,具有超强的抗炎、杀菌功效,有效降低痤疮丙酸杆菌、表皮葡萄球菌等的活性,抑制痤疮的生成,特别是对于易长粉刺、痘痘肌肤最不可或缺的护理产品。
本发明中的龙血提取物,标准中文名称:麒麟竭提取物(CAS号:84776-31-8),从龙血树藤中提取出来的活性物,具有超强的抗氧化能力,活性成分为50%塔斯品碱(强抗氧化)+原花青素(PAC),通过关键的纤维状网络重新合成(胶原蛋白IV,胶原蛋白Ⅲ,纤维连结蛋白,以及整合素β4分子合成),修复真皮表皮的连接,可增强线粒体酶活性,促进表皮基底再造,充盈真皮层,达到祛疤痕,祛痘印,修复肌肤等功效。
本发明中的水杨酸衍生物,标准中文名称:水杨酸(CAS号:69-72-7),为白柳树皮中提取的活性物,具有强大的抑菌、消炎去角质功效,抑菌消炎,溶解老化角质细胞,清除毛孔中多余皮脂。
本发明中的菩提树(FICUSRELIGIOSA)提取物为天然植物提取液,提取液性质温和,不易过敏,具有治疗皮肤病、防止皮肤老化、促进新陈代谢、淡斑等功效。
本发明的全效控油、祛痘、净痘美肌精华液,完全符合国家颁布的《化妆品卫生规范》(2007版)中的各项指标,该组合物不含有任何有毒物质。
本发明的全效控油、祛痘、净痘美肌精华液,是一种精华浓缩液,可直接涂抹,主要用于面部和颈部。
本发明的有益效果为:
1、本发明的全效控油、祛痘、净痘美肌精华液配方组成上采用本发明提供的野大豆籽提取物、鱼星草提取物与龙血提取物、黄柏提取物、水杨酸衍生物完美搭配,野大豆籽提取物强大的抑制皮脂腺细胞分化、调节油脂分泌功效,鱼星草提取物具有超强的抗炎解毒力,能增强机体免疫功能,增加白细胞吞噬能力,龙血提取物强大的氧化能力,快速清除自由基,促进胶原蛋白合成,提高受损肌肤愈合能力,黄柏提取物与水杨酸衍生物强大的抗菌的作用完美结合,改善因精神压力、疲劳、空气污染、紫外线伤害、不健康的饮食和作息习惯等原因对皮肤造成的伤害,导致皮肤干燥、粗糙、没弹性、肤色黯哑、满脸痘痘等问题,造就了独有的全效控油、祛痘、净痘美肌精华液,美肤护理,帮助肌肤持续控油、畅通毛孔、细致毛孔、祛除痘痘、抚平痘痕,获得光滑细腻肤感;
2、本发明全效控油、祛痘、净痘美肌精华液配方中进一步采用菩提树(FICUSRELIGIOSA)提取物,菩提树(FICUSRELIGIOSA)提取物与龙血提取物结合,更有效祛除肌肤因为痘痘产生的红肿,加快促进肌肤新陈代谢、提高肌肤愈合能力,快速消除痘印,提升肌肤免疫力,强化肤质的同时减低过敏及出痘的机率。
具体实施方式
下面结合具体实施例对本发明作具体说明。
实例1
一种全效控油、祛痘、净痘美肌精华液,组成如下(按重量百分比):
野大豆籽提取物:0.1%
鱼腥草提取物:0.5%
黄柏提取物:1%
龙血提取物:0.1%
水杨酸衍生物:5ppm
甘油:5%
丁二醇:3%
羟乙基脲:1%
甜菜碱:0.5%
黄原胶:0.3%
羟苯甲酯:0.1%
苯氧乙醇:0.5%
PEG-40氢化蓖麻油:0.05%
香精:0.005%
去离子水:加至100%。
上述配方中甘油、丁二醇、羟乙基脲、甜菜碱为基础保湿剂,黄原胶、羟苯甲酯、苯氧乙醇、PEG-40氢化蓖麻油和香精为辅助成分。
本发明制备方法是:先高温80-85℃溶解完全后,降温至45℃,加已预混合均匀的PEG-40氢化蓖麻油与香精,搅至透明后,依次加入余下组分,每加一个组分应搅拌、混合充分溶解完全,才能加下一个原料,加完后搅至完全透明均一即可,制得产品1。
使用方法:洁肤后,取适量轻轻涂抹于脸部,早晚使用。
功效:帮助肌肤持续控油,畅通毛孔,细致毛孔,祛除痘痘,抚平痘痕,获得光滑细腻肤感。
实例2至实例4
按以下表1中指定的野大豆籽提取物、鱼腥草提取物、黄柏提取物与龙血提取物、水杨酸衍生物和其它肤质调理剂含量重复实施例1的制备方法,分别得到不同组分的净痘美肌精华产品,由于水和其它肤质调理剂(包括基础保湿剂和辅助成分)对产品功效几乎无影响,因此,在此配方中不进行具体举例:
表1
配方成分 | 实施例2 | 实施例3 | 实施例4 | 实施例5 |
野大豆籽提取物 | 0.3% | 0.5% | 1% | 1.5% |
鱼腥草提取物 | 0.8% | 1% | 1.5% | 2% |
黄柏提取物 | 1.5% | 2% | 2.5% | 3% |
龙血提取物 | 0.2% | 0.3% | 0.5% | 1% |
水杨酸衍生物 | 5ppm | 5ppm | 5ppm | 5ppm |
甘油 | 1-5% | 1-5% | 1-5% | 1-5% |
丁二醇 | 0.5-10% | 0.5-10% | 0.5-10% | 0.5-10% |
羟乙基脲 | 1-3% | 1-3% | 1-3% | 1-3% |
甜菜碱 | 0.5-2% | 0.5-2% | 0.5-2% | 0.5-2% |
辅助成分 | 0.5-3% | 0.5-3% | 0.5-3% | 0.5-3% |
去离子水 | 加至100% | 加至100% | 加至100% | 加至100% |
得到 | 产品2 | 产品3 | 产品4 | 产品5 |
将实例1至实例5中制得的净痘美肌精华液产品1~产品5,与现有的净痘美肌精华产品进行临床实验对比,临床实验条件为:志愿者50名男性,年龄18-35岁,每天使用2次,连续使用28天,实验结果如表2所示:
表2
测试项目 | 现有产品 | 产品1 | 产品2 | 产品3 | 产品4 | 产品5 |
细致毛孔 | 提高3% | 提高15% | 提高25% | 提高35% | 提高40% | 提高40% |
皮脂控油 | 未见提高 | 提高25% | 提高40% | 提高42% | 提高45% | 提高45% |
光滑肤感 | 未见提高 | 提高7% | 提高7% | 提高8% | 提高12% | 提高15% |
修复痘印 | 未见提高 | 提高20% | 提高25% | 提高35% | 提高40% | 提高40% |
从表2可看出产品1至产品5肌肤的改善均有显著提高,效果比现有产品明显,其中,以产品5效果最佳。
实施例6至实施例8
按以下表3中指定的野大豆籽提取物、鱼腥草提取物、黄柏提取物与龙血提取物、水杨酸衍生物、菩提树(FICUSRELIGIOSA)提取物和其它肤质调理剂含量重复实施例1的制备方法,分别得到不同组分的净痘美肌精华产品,由于水和其它肤质调理剂(包括基础保湿剂和辅助成分)对产品功效几乎无影响,因此,在下述配方中不进行具体举例:
表3
将实例6至实例8中制得的净痘美肌精华液产品6至产品8,与产品2至产品4及现有的净痘美肌精华产品进行临床实验对比,临床实验条件为:志愿者10名男性,年龄18-35岁,每天使用2次,跟踪记录痘痘从消除红肿、抚平至痘印消除所用天数,结果如表4所示:
表4
从表2可看出产品3至产品8其从消除痘痘红肿、抚平痘痕至消除痘印均比现有产品要快,而产品6~8比产品3~5其消除痘印的天数更短,所需时间为一个月内,可见添加有菩提树(FICUSRELIGIOSA)提取物的精华液消除痘印更快,效果更为显著。
以上所述,仅为本发明的较佳实施例,并不用以限制本发明,凡是依据本发明的技术实质对以上实施例所作的任何细微修改、等同替换和改进,均应包含在本发明技术方案的保护范围内。
Claims (6)
1.一种全效控油、祛痘、净痘美肌精华液,其特征在于,其包括按重量百分比计的以下组分:
野大豆籽提取物:0.1-2%
鱼腥草提取物:0.5-3%
黄柏提取物:1-5%
龙血提取物:0.1-1%
水杨酸衍生物:5-20ppm
甘油:1-5%
丁二醇:0.5-10%
羟乙基脲:1-3%
甜菜碱:0.5-2%
辅助成分:0.5-3%
去离子水:余量。
2.根据权利要求1所述的全效控油、祛痘、净痘美肌精华液,其特征在于,其包括按重量百分比计的以下组分:
野大豆籽提取物:1-2%
鱼腥草提取物:1-3%
黄柏提取物:2-4%
龙血提取物:0.5-1%
水杨酸衍生物:5-20ppm
甘油:1-5%
丁二醇:0.5-10%
羟乙基脲:1-3%
甜菜碱:0.5-2%
辅助成分:0.5-3%
去离子水:余量。
3.根据权利要求2所述的全效控油、祛痘、净痘美肌精华液,其特征在于,其包括按重量百分比计的以下组分:
野大豆籽提取物:1.5%
鱼腥草提取物:2%
黄柏提取物:3%
龙血提取物:1%
水杨酸衍生物:5ppm
甘油:1-5%
丁二醇:0.5-10%
羟乙基脲:1-3%
甜菜碱:0.5-2%
辅助成分:0.5-3%
去离子水:余量,
以上各组分之和为100%。
4.根据权利要求1所述的全效控油、祛痘、净痘美肌精华液,其特征在于,还包括有适量菩提树(FICUSRELIGIOSA)提取物。
5.根据权利要求4所述的全效控油、祛痘、净痘美肌精华液,其特征在于,所述菩提树(FICUSRELIGIOSA)提取物与龙血提取物的重量比为(0.5~1):1。
6.根据权利要求1至4之一所述的全效控油、祛痘、净痘美肌精华液,其特征在于,所述辅助成分包括并不限于赋香剂、防腐剂、增溶剂、增稠剂、辅助皮肤调理剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511030166.9A CN105395441B (zh) | 2015-12-30 | 2015-12-30 | 一种全效控油、祛痘、净痘美肌精华液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511030166.9A CN105395441B (zh) | 2015-12-30 | 2015-12-30 | 一种全效控油、祛痘、净痘美肌精华液 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105395441A true CN105395441A (zh) | 2016-03-16 |
CN105395441B CN105395441B (zh) | 2019-10-11 |
Family
ID=55461442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511030166.9A Active CN105395441B (zh) | 2015-12-30 | 2015-12-30 | 一种全效控油、祛痘、净痘美肌精华液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105395441B (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105662981A (zh) * | 2016-03-30 | 2016-06-15 | 徐鸣 | 双效修护精华原液 |
CN106913493A (zh) * | 2017-05-04 | 2017-07-04 | 广州诺胜化妆品有限公司 | 一种龙血舒缓喷雾及制备方法 |
CN106983692A (zh) * | 2017-05-19 | 2017-07-28 | 广州蜜妆生物科技有限公司 | 一种植物酵素控油祛痘面膜 |
CN107233224A (zh) * | 2017-07-06 | 2017-10-10 | 广州市花安堂生物科技有限公司 | 一种细致表皮毛孔的组合物和由其组成的化妆品 |
CN107349149A (zh) * | 2017-07-25 | 2017-11-17 | 广州铭心化妆品有限公司 | 一种祛痘精华液及其制备方法 |
CN108434032A (zh) * | 2018-04-27 | 2018-08-24 | 安婕妤化妆品科技股份有限公司 | 一种祛痘护肤品及其制备方法 |
CN108619060A (zh) * | 2018-07-09 | 2018-10-09 | 广州赛莱拉干细胞科技股份有限公司 | 一种石斛保湿嫩肤组合物及其用途 |
CN109893475A (zh) * | 2017-12-08 | 2019-06-18 | 思琴克株式会社 | 包含植物提取混合物的抗菌、抗炎、抗氧化、皮脂分泌抑制及皮肤炎改善用组合物 |
CN110638728A (zh) * | 2019-11-14 | 2020-01-03 | 广州一一生物技术有限公司 | 一种祛痘淡印的皮肤护理组合物及其制备方法和应用 |
CN115501157A (zh) * | 2022-10-18 | 2022-12-23 | 贵州咕咚姑娘大健康有限责任公司 | 一种用于祛痘修复痘印抗衰老保湿美白的面膜及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000319159A (ja) * | 1999-05-10 | 2000-11-21 | Nonogawa Shoji Kk | 皮膚外用剤 |
CN102178809A (zh) * | 2011-04-26 | 2011-09-14 | 王祥国 | 一种皮肤外用药物及其加工成药剂的方法 |
CN103751055A (zh) * | 2014-01-06 | 2014-04-30 | 孙贵雨 | 一种痤疮面膜 |
-
2015
- 2015-12-30 CN CN201511030166.9A patent/CN105395441B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000319159A (ja) * | 1999-05-10 | 2000-11-21 | Nonogawa Shoji Kk | 皮膚外用剤 |
CN102178809A (zh) * | 2011-04-26 | 2011-09-14 | 王祥国 | 一种皮肤外用药物及其加工成药剂的方法 |
CN103751055A (zh) * | 2014-01-06 | 2014-04-30 | 孙贵雨 | 一种痤疮面膜 |
Non-Patent Citations (2)
Title |
---|
小P老师: "《媲美明星3.心机美颜术》", 31 October 2012, 南京江苏人民出版社 * |
王勇: "《我的家庭美容院》", 31 May 2007, 中国纺织出版社 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105662981A (zh) * | 2016-03-30 | 2016-06-15 | 徐鸣 | 双效修护精华原液 |
CN105662981B (zh) * | 2016-03-30 | 2018-07-10 | 徐鸣 | 双效修护精华原液 |
CN106913493A (zh) * | 2017-05-04 | 2017-07-04 | 广州诺胜化妆品有限公司 | 一种龙血舒缓喷雾及制备方法 |
CN106983692A (zh) * | 2017-05-19 | 2017-07-28 | 广州蜜妆生物科技有限公司 | 一种植物酵素控油祛痘面膜 |
CN106983692B (zh) * | 2017-05-19 | 2019-12-13 | 广州蜜妆生物科技有限公司 | 一种植物酵素控油祛痘面膜 |
CN107233224A (zh) * | 2017-07-06 | 2017-10-10 | 广州市花安堂生物科技有限公司 | 一种细致表皮毛孔的组合物和由其组成的化妆品 |
CN107349149A (zh) * | 2017-07-25 | 2017-11-17 | 广州铭心化妆品有限公司 | 一种祛痘精华液及其制备方法 |
CN109893475A (zh) * | 2017-12-08 | 2019-06-18 | 思琴克株式会社 | 包含植物提取混合物的抗菌、抗炎、抗氧化、皮脂分泌抑制及皮肤炎改善用组合物 |
CN108434032A (zh) * | 2018-04-27 | 2018-08-24 | 安婕妤化妆品科技股份有限公司 | 一种祛痘护肤品及其制备方法 |
CN108619060A (zh) * | 2018-07-09 | 2018-10-09 | 广州赛莱拉干细胞科技股份有限公司 | 一种石斛保湿嫩肤组合物及其用途 |
CN110638728A (zh) * | 2019-11-14 | 2020-01-03 | 广州一一生物技术有限公司 | 一种祛痘淡印的皮肤护理组合物及其制备方法和应用 |
CN115501157A (zh) * | 2022-10-18 | 2022-12-23 | 贵州咕咚姑娘大健康有限责任公司 | 一种用于祛痘修复痘印抗衰老保湿美白的面膜及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105395441B (zh) | 2019-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105395441A (zh) | 一种全效控油、祛痘、净痘美肌精华液 | |
US10675488B2 (en) | Acne removing skin care product and preparation method thereof | |
CN103520053B (zh) | 洗发沐浴粉 | |
JP5791879B2 (ja) | NF−κB活性化抑制剤ならびに毛穴ケア剤 | |
KR100960054B1 (ko) | 탈모방지 및 두피개선을 위한 두발 화장품 조성물 | |
CN106983692A (zh) | 一种植物酵素控油祛痘面膜 | |
CN104958222A (zh) | 一种冰川固态水 | |
CN106798686A (zh) | 一种不含硅油的保湿舒敏的乳霜及其制备方法 | |
US20150086522A1 (en) | Formulation containing herb infused aloe | |
CN106580732A (zh) | 一种乳液及其制备方法 | |
CN110787119A (zh) | 一种抗菌护肤中药组合物及其制备方法和应用 | |
CN104188859B (zh) | 一种含天然成分提取物的抗皱嫩肤乳液及其制备方法 | |
WO2017197688A1 (zh) | 人体清洁剂及其制备方法 | |
CN104248548A (zh) | 植物提取物抗氧化精华液 | |
CN116251047B (zh) | 一种含牛蒡根提取物的控油洗发剂及其制备方法 | |
CN106726780A (zh) | 一种女性私处护理沐浴露 | |
US20230042135A1 (en) | Herbal shampoo composition and method for preparing the same | |
CN103432064A (zh) | 一种用于治疗青春痘色素沉斑和美白的膏霜 | |
CN103405370B (zh) | 纯果水草药醋美肤喷雾及其制备方法 | |
CN105380873A (zh) | 一种含有白刺籽油的补水保湿精华素 | |
CN106177192B (zh) | 一种双组分用于治疗头油与头屑的复方药物及其制备方法 | |
CN108158961A (zh) | 一种具有修护作用的茶树口红 | |
CN108158963A (zh) | 一种具有抗菌消炎抗氧化的茶树口红 | |
CN107595709A (zh) | 一种抗粉刺剂及其应用 | |
CN105055216A (zh) | 一种护肤品用天然复合赋香剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A full effect oil control, acne elimination and skin beautifying essence Granted publication date: 20191011 Pledgee: Guangdong Provincial Bank of Communications Co.,Ltd. Pledgor: GUANGZHOU MESTRACT BIO-TECH Co.,Ltd. Registration number: Y2024980019621 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |